Ema, Lou Yi Joy P.

HRN: 19-84-59  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/18/2022
CEFTRIAXONE 1G (VIAL)
05/18/2022
05/25/2022
IV
1g
Q24h
Pcap C
Waiting Final Action 
05/20/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/20/2022
05/27/2022
IV
1gm
Q6
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: